Baker McKenzie advised Mundipharma GmbH on its sale of their Limburg based production plant to Fidelio Healthcare Holding GmbH. Fidelio Healthcare will continue the Mundipharma business in Limburg and take over most of the employees. Plans are to produce its own products as well as medicine by order of other companies at this location.
Pharmaceutical products, that were produced in Limburg until now, will be fabricated by Fidelio for Mundipharma in the future. The contract was signed by both parties on February 20, 2018. The acquisition is subject to the approval by the responsible antitrust authorities.
"The transaction is part of our client's strategic realignment. It allows the preservation of the Limburg location with about 100 jobs at the same time,. With our team we were able to contribute to the successful sale of the production plants from a legal point of view", comments Corporate/M&A-Partner Christian Atzler.
Mundipharma is a research company, developing highly efficient medicine with a maximum of tolerability. Not only by their own progression, but also thanks to promising cooperation, Mundipharma offers access to innovative therapy for a high number of patients.
Fidelio Healthcare, located in Seefeld, Bavaria, offers global consulting services for the healthcare and life-science industry.
Baker McKenzie's Corporate / M&A team regularly advises on domestic and international transactions and restructurings. Most recently, Baker McKenzie advised Rexnord on the acquisition of CENTA Group, LKQ Corporation on the acquisition of the Stahlgruber GmbH, Sika on the acquisition of Faist ChemTec, Materialize NV on the acquisition of ACTech GmbH, Sulzer AG on the acquisition of Transcodent, Trimble on the acquisition of Müller-Elektronik, Tokheim Service Group on a strategic partnership with Kärcher, SPIE on the acquisition of LÜCK Group, Grünenthal Group on the acquisition of Adhesys Medical GmbH, Flowserve Corporation on the sale of the Gestra Group, ZF Friedrichshafen on the sale of the Cherry Group, GFKL on the acquisition of the Tesch Group and CORESTATE on the acquisition of HFS Financial Services and Hannover Leasing.
Legal Advisors to Mundipharma GmbH:
Baker McKenzie
Lead: Corporate/M&A: Christian Atzler (partner, Frankfurt)
Team: Corporate/M&A: Nikolas Lazaridis (associate, Frankfurt), Kai Schlender (associate, Frankfurt)
Pharma/Regulatory: Dr. Thilo Räpple (partner, Frankfurt), Dr. Martin Altschwager (associate, Frankfurt)
Real Estate: Dr. Florian Thamm (partner, Frankfurt), Dr. Niklas Wielandt (associate, Frankfurt)
Banking & Finance: Kathrin Marchant (partner, Frankfurt)
Antitrust: Christian Horstkotte (partner, Düsseldorf)
